MOTS-c is one of the more scientifically interesting compounds in this library
because of where it comes from — but the human evidence base is thin, and this
monograph is honest about that.
Chemical identity & structure.
MOTS-c ("mitochondrial open reading frame of the twelve-S rRNA type-c") is a
16-amino-acid peptide. Its distinguishing feature is its origin: it is encoded
within the mitochondrial genome, in a short open reading frame inside the 12S
rRNA region — making it one of a small group of "mitochondrial-derived
peptides". Most peptides are encoded in the nuclear genome; MOTS-c is not.
Mechanism of action.
MOTS-c is described in the research literature as a metabolic regulator. The
most-reported mechanism is activation of the AMPK pathway — a central cellular
energy sensor — with downstream effects on glucose handling and insulin
sensitivity. It has also been reported to translocate to the cell nucleus under
metabolic stress and influence gene expression. Because it appears to track
exercise-related signaling, it is sometimes described as an "exercise-mimetic",
though that framing is more marketing than established science.
Key research findings.
Preclinical research — primarily in rodents and cell models — reports effects on
insulin sensitivity, metabolic flexibility, and age-related metabolic decline.
MOTS-c levels in humans have been studied as a biomarker associated with
exercise and metabolic state.
The research / citation base.
The MOTS-c literature is predominantly preclinical. Human data is largely
observational (associating circulating MOTS-c with metabolic or fitness
measures) rather than interventional. Well-powered human trials of MOTS-c
administration are essentially absent. Its human safety and efficacy profile
should be considered unestablished.
Human clinical trial data.
No human clinical trial has established administration parameters for MOTS-c; VialTalk does not provide community-sourced dosing.
Quality & sourcing notes.
A defined 16-mer should have a batch-specific COA reporting identity by mass
spectrometry and purity by HPLC. Given the compound's popularity relative to its
thin evidence base, sourcing skepticism is warranted.
*Research-use note: Educational summary of published research. MOTS-c is not an
approved drug; this is research context only and not medical advice.*
